通心络对家兔动脉粥样硬化模型VCAM-1及PAI-1表达的影响
本文关键词: 动脉粥样硬化 血管细胞黏附因子1 纤溶酶原激活剂抑制剂1 通心络 出处:《吉林大学》2011年硕士论文 论文类型:学位论文
【摘要】:背景与目的: AS已成为威胁人类健康,引起死亡的主要疾病。可导致全身多个靶器官损害,严重影响人民的生活质量。为从根本解决AS为人民带来的困扰,大量基础实验及临床观察致力于对AS发病机制及治疗方法的研究。本研究通过高脂饮食建立家兔AS模型,了解PAI-1和VCAM-1在AS家兔血清和病变局部的表达,观察通心络对PAI-1和VCAM-1的影响及其抗AS的作用机制。 资料与方法: 一、建立家兔AS模型,采用酶联免疫夹心法、免疫组化方法检测VCAM-1和PAI-1在正常饮食组和高脂饮食组家兔血清中及动脉血管壁的表达。 (一)动物模型的建立 1、实验动物和分组 雄性大耳白兔24只。随机分为常规饮食组、高脂饮食组、通心络组,每组8只,饲养14周。 2、病理标本的制作 14周末处死动物,常规病理切片,H-E染色。 3、高脂血症的确立 正常饮食组和高脂饮食组实验前(0周)血清中TC、TG、LDL无显著性差异(P0.01);正常饮食组14周TC、TG、LDL与0周比较无显著性差异(P0.01);高脂饮食组14周TC、TG、LDL明显增高,与0周比较有显著性差异(P0.01)。 (二)酶联免疫夹心法检测VCAM-1和PAI-1在正常饮食组和高脂饮食组血清中的表达 1、VCAM-1在正常饮食组和高脂饮食组血清中的表达 正常饮食组的血清中VCAM-1水平在0周、14周无显著差别(P0.01);高脂饮食组血清中VCAM-1水平14周较0周显著增高(P0.01)。 2. PAI-1在正常饮食组和高脂饮食组血清中的表达 正常饮食组血清中PAI-1水平在0周、14周无显著差别(P0.01);高脂饮食组血清中PAI-1的水平14周较0周显著增高(P0.01)。 (三)免疫组化检测VCAM-1和PAI-1在正常饮食组和高脂饮食组主动脉壁的表达 1、VCAM-1在正常饮食组和高脂饮食组主动脉壁的阳性表达 正常饮食组主动脉内膜和中膜仅见散在棕黄色颗粒状阳性染色物质,阳性染色百分比为2.92±0.31%。高脂饮食组增厚的动脉内膜及中膜内可见大量的棕黄色颗粒状阳性染色物质,阳性染色百分比为18.38±2.55%,明显高于正常饮食组(P0.01)。 2、PAI-1在正常饮食组和高脂饮食组主动脉壁的阳性表达 正常饮食组主动脉内膜和中膜仅见散在棕黄色颗粒状阳性染色物质,阳性染色百分比为3.24±0.21%。高脂饮食组增厚的动脉内膜及中膜内可见大量的棕黄色颗粒状阳性染色物质,尤以内膜明显,阳性染色百分比为15.46±2.23%,明显高于正常饮食组(P0.01)。 二、通心络的调脂作用 实验前三组动物血清TC、TG、LDL无差异(P0.01),14周时正常饮食组TC、TG、LDL与0周比较无显著性差异(P0.01);14周时高脂饮食组和通心络组TC、TG、LDL明显增高,明显高于正常饮食组(P0.01);高脂饮食组和通心络组比较,14周时通心络组血清TC、TG、LDL较高脂饮食组明显下降(P0.01)。 三、通心络对VCAM-1和PAI-1表达的影响 (一)通心络对血清VCAM-1和PAI-1表达的影响 1、通心络对血清VCAM-1表达的影响 三组动物血清中VCAM-1水平在0周无显著差别(P0.01);饲养14周时高脂饮食组和通心络组血清中VCAM-1水平较0周显著增高(P0.01),并高于正常饮食组(P0.01);14周时通心络组血清中VCAM-1较高脂饮食组明显下降(P0.01)。 2、通心络对血清PAI-1表达的影响 三组动物血清中PAI-1水平在0周无显著差别(P0.01);饲养14周时高脂饮食组和通心络组血清中PAI-1水平较0周增高(P0.01),并高于正常饮食组(P0.01);14周时通心络组血清中PAI-1较高脂饮食组明显下降(P0.01)。 (二)通心络对主动脉壁VCAM-1和PAI-1阳性染色百分比的影响 1、通心络对主动脉壁VCAM-1阳性染色百分比的影响 高脂饮食组和通心络组增厚的动脉内膜及中膜内可见较多的棕黄色颗粒状阳性染色物质,表达量分别为18.38±2.55%和13.18±1.25%。通心络组的阳性表达百分比较高脂饮食组明显降低(P0.01)。 2、通心络对主动脉壁PAI-1阳性染色百分比的影响 高脂饮食组和通心络组增厚的动脉内膜及中膜内可见较多的棕黄色颗粒状阳性染色物质,表达量分别为15.46±2.23%和9.45±1.09%。通心络组的阳性表达百分比较高脂饮食组明显降低(P0.01)。 以上实验结果以平均数±标准差(X±S)表示,自身及组间对照采用t检验,P0.05有显著性差异。结果: 1.高脂饮食组和通心络组14周后血清TC、TG、LDL较实验前明显升高(P0.01),并且高于对照组(P0.01),通心络组血清TC、TG、LDL较高脂饮食组明显下降(P0.01)。 2.高脂饮食组和通心络组14周后血清PAI-1和VCAM-1的水平较0周显著增高(P0.01),并且高于对照组(P0.01),通心络组PAI-1和VCAM-1的水平明显低于高脂饮食组(P0.01)。 3.免疫组化分析显示:高脂饮食组增厚的动脉内膜及中膜内可见大量的棕黄色颗粒状阳性染色物质,部分融合成片,尤以内膜明显,通心络组阳性染色物质明显低于高脂饮食组,三组组间比较有显著性差异(P0.01)。 结论: 1、AS家兔血清中VCAM-1和PAI-1的表达增高;家兔主动脉粥样硬化病变局部VCAM-1和PAI-1阳性表达百分比增高。VCAM-1和PAI-1的过度表达可能是AS发生机制之一。 2、通心络能够减少AS家兔VCAM-1和PAI-1在血清中及主动脉粥样硬化病变局部阳性表达百分比。抑制VCAM-1和PAI-1的表达可能是通心络抗AS机制之一。 3、通心络不但具有调脂的作用,并且具有减轻和抑制AS的作用。 4、检测血清中VCAM-1和PAI-1,对于早期诊断AS性疾病以及监测AS的发生、发展及转归有着重要的意义。
[Abstract]:Background and purpose:
AS has become a threat to human health, mainly caused by the disease can lead to death. More than one target organ damage, seriously affecting people's quality of life. In order to fundamentally solve the AS problems for people, a large number of basic experiments and clinical observation of AS is devoted to the study of pathogenesis and therapy. The study of rabbit AS model the high fat diet, understand PAI-1 and VCAM-1 expression in serum and AS local lesions in rabbits, observe the mechanism effect of Tongxinluo on PAI-1 and VCAM-1 and anti AS.
Information and methods:
First, the rabbit AS model was established. The expression of VCAM-1 and PAI-1 in serum and arterial wall of normal diet group and high-fat diet group were detected by enzyme-linked immunosorbent assay and immunohistochemistry.
(I) establishment of animal model
1, experimental animals and groups
24 male large white rabbits were randomly divided into regular diet group, high fat diet group, Tongxinluo group and 8 rats in each group for 14 weeks.
2, the preparation of pathological specimen
The animals were killed at the end of the 14 week, routine pathological section, H-E staining.
3, the establishment of hyperlipidemia
There was no significant difference in serum TC, TG and LDL between the normal diet group and the high-fat diet group before the experiment (0 weeks) (P0.01). There was no significant difference in TC, TG, LDL between the normal diet group and the 0 week group (P0.01). The 14 week TC, TG and LDL increased significantly in the high-fat diet group, which was significantly different from that in the 0 week (TC).
(two) the expression of VCAM-1 and PAI-1 in the serum of the normal diet group and the high fat diet group by enzyme linked immunosorbent assay
1, the expression of VCAM-1 in the serum of the normal diet group and the high fat diet group
The level of VCAM-1 in the serum of the normal diet group was 0 weeks, and there was no significant difference in the 14 weeks (P0.01), and the level of VCAM-1 in the serum of high fat diet group was significantly higher than that in the 0 week (P0.01).
2. PAI-1 expression in the serum of the normal diet group and the high fat diet group
There was no significant difference in the level of PAI-1 in the serum of the normal diet group for 0 weeks and 14 weeks (P0.01), and the level of PAI-1 in the serum of the high fat diet group was significantly higher than that in the 0 week (P0.01).
(three) immunohistochemical detection of the expression of VCAM-1 and PAI-1 in the aorta wall of the normal diet group and the high fat diet group
1, the positive expression of VCAM-1 in the aorta wall of the normal diet group and the high fat diet group
Normal diet group aortic intima and media were scattered in the yellow brown granular staining material, positive staining percentage was 2.92 + 0.31%. arterial intimal thickening of the high fat diet group and in the film can be seen in the large brown granular staining material, positive staining percentage was 18.38 + 2.55%, significantly higher than the normal diet group (P0.01).
2, the positive expression of PAI-1 in the aorta wall of the normal diet group and the high fat diet group
Normal diet group aortic intima and media were scattered in the yellow brown granular staining material, positive staining percentage was 3.24 + 0.21%. arterial intimal thickening of the high fat diet group and in the film can be seen in the large brown granular staining material, especially in endometrial. Positive staining percentage was 15.46 + 2.23%, significantly higher than the normal diet group (P0.01).
Two, the lipid-regulating effect of Tongxinluo
Before the experiment three group animal serum TC, TG, LDL no difference (P0.01), TC, normal diet group at 14 weeks compared with 0 weeks TG, LDL no significant difference (P0.01); 14 weeks of high fat diet group and Tongxinluo group TC, TG, LDL increased significantly, significantly higher than the normal diet group (P0.01); high fat diet group and Tongxinluo group, 14 weeks Shitong Tongxinluo group serum TC, TG, LDL in high fat diet group decreased significantly (P0.01).
Three, the effect of Tongxinluo on the expression of VCAM-1 and PAI-1
(1) the effect of Tongxinluo on the expression of serum VCAM-1 and PAI-1
1, the effect of Tongxinluo on the expression of serum VCAM-1
The VCAM-1 levels of the three groups in animal serum had no significant difference in the 0 week (P0.01); 14 weeks of feeding, high fat diet group and Tongxinluo group serum VCAM-1 levels were significantly increased in 0 weeks (P0.01), and higher than the normal diet group (P0.01); VCAM-1 high fat diet for 14 weeks Shitong Tongxinluo group decreased (P0.01).
2, the effect of Tongxinluo on the expression of serum PAI-1
The PAI-1 levels of the three groups in animal serum had no significant difference in the 0 week (P0.01); 14 weeks of feeding, high fat diet group and Tongxinluo group in the serum PAI-1 level was 0 Zhou Zenggao (P0.01), and higher than the normal diet group (P0.01); PAI-1 high fat diet for 14 weeks Shitong Tongxinluo group was significantly decreased (P0.01).
(two) the effect of Tongxinluo on the percentage of VCAM-1 and PAI-1 positive staining in the aortic wall
1, the effect of Tongxinluo on the percentage of VCAM-1 positive staining in the aortic wall
In the high fat diet group and Tongxinluo group, there were more brown and granular positive staining substances in the intima and middle membrane. The expression levels were 18.38 + 2.55% and 13.18 + 1.25%. respectively. The percentage of positive expression in Tongxinluo group was significantly lower than that in the high-fat diet group (P0.01).
2, the effect of Tongxinluo on the percentage of PAI-1 positive staining in the aortic wall
In the high fat diet group and Tongxinluo group, there were more brown and granular positive staining substances in the intima and middle membrane. The expression levels were 15.46 + 2.23% and 9.45 + 1.09%. respectively. The percentage of positive expression in Tongxinluo group was significantly lower than that in the high-fat diet group (P0.01).
The above experimental results were expressed with mean standard deviation (X + S). T test was used in self and group control, and there were significant differences in P0.05.
1., after 14 weeks of high fat diet group and Tongxinluo group, serum TC, TG and LDL increased significantly (P0.01), which was higher than that of the control group (P0.01). The serum TC, TG and LDL of the Tongxinluo group were significantly lower than those of the high-fat diet group (P0.01).
2., after 14 weeks of high fat diet group and Tongxinluo group, serum PAI-1 and VCAM-1 levels increased significantly compared with 0 weeks (P0.01), and higher than those in control group (P0.01). The levels of PAI-1 and VCAM-1 in Tongxinluo group were significantly lower than those in high-fat diet group (P0.01).
3. immunohistochemical analysis showed that intimal thickening in cholesterol diet group and in the film can be seen in the large brown granular staining material, partial integration into the film, especially in endometrial. Tongxinluo group positive substance was significantly lower than that in high fat diet group, there were significant differences between the three groups (P0.01).
Conclusion:
1, the expression of VCAM-1 and PAI-1 increased in serum of AS rabbits. The percentage of positive expression of VCAM-1 and PAI-1 in aorta atherosclerotic lesion of rabbits increased, and the over expression of.VCAM-1 and PAI-1 might be one of the mechanisms of AS.
2, Tongxinluo can reduce the percentage of positive expression of VCAM-1 and PAI-1 in serum and atherosclerotic lesion in AS rabbits. Inhibition of VCAM-1 and PAI-1 expression may be one of the mechanisms of Tongxinluo AS.
3, Tongxinluo not only has the effect of lipid-regulating, but also has the effect of reducing and inhibiting AS.
4, the detection of VCAM-1 and PAI-1 in serum is of great significance for the early diagnosis of AS disease and the monitoring of the occurrence, development and prognosis of AS.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2011
【分类号】:R-332
【相似文献】
相关期刊论文 前10条
1 张颖;;通心络治疗高血压性肾损害的研究[J];中国中医基础医学杂志;2011年08期
2 杨叁平;;中药通心络稳定动脉硬化斑块获国际认同[J];中国卫生产业;2010年08期
3 王英霞;黄丽琴;赵少伟;;通心络联合丹参注射液治疗稳定型心绞痛50例[J];临床误诊误治;2011年S1期
4 臧天霞;孙伟娟;邹宝琦;;通心络治疗糖尿病周围神经病变40例[J];实用中医内科杂志;2009年12期
5 孙彬;何穗智;;主成分分析法在通心络对心动功能改善评价中的应用[J];数理医药学杂志;2011年02期
6 吴远华;曹丽平;朱广旗;邵勇;黄nr;;灯盏细辛注射液对急性脑梗死患者血浆中t-PA和PAI-1水平的影响[J];广东医学;2011年10期
7 姜建涛;周斌;张淑群;李少民;张潍;张晋;乔哲;孔冉冉;马跃峰;;血浆uPA、PAI-1浓度与食管鳞状细胞癌临床病理因素的相关性[J];现代肿瘤医学;2011年07期
8 尹梅;高海青;李保应;程梅;吴守彩;王昊;;通心络对糖尿病大鼠心肌RAGE、NF-κB的影响[J];山东大学学报(医学版);2011年08期
9 黄晓忠;余细勇;刘晓颖;林秋雄;单志新;符永恒;林曙光;吴以岭;吴伟康;;通心络对高血压、高血糖合并高胆固醇血症大鼠动脉的影响及机制[J];广东医学;2011年12期
10 鲁叶弘;付强;曾定尹;;血管外膜炎症大鼠核转录因子NF-κB、白介素-6、白介素-10的表达及通心络的干预研究[J];中国医药导报;2011年16期
相关会议论文 前10条
1 刘日辉;曾定尹;;通心络对大鼠血管外膜损伤中神经源性一氧化氮合酶的影响及作用机制的研究[A];第十次中国中西医结合学会心血管病学术大会暨第五次江西省中西医结合学会心血管病学术大会论文汇编[C];2010年
2 李蕾;吴秋枫;耿丽娜;;彩超对通心络治疗老年动脉粥样硬化的评价[A];第十一次全国中西医结合影像学术研讨会暨全国中西医结合影像学研究进展学习班资料汇编[C];2010年
3 廖奕华;邓静修;邓云梅;刘湘;;通心络治疗慢性充血性心衰的疗效观察[A];第六次全国中西医结合心血管会学术会议论文汇编[C];2002年
4 闵fy;章兰芳;钟雁;夏玉叶;盛雨辰;;通心络对血栓形成和纤溶系统的影响[A];中国制药工业药理学会20周年学术会议论文集[C];2002年
5 蔡定芳;阮晴雯;陈锡群;王竹行;吴桂华;沈思佳;赵钢;刘静;;通心络治疗急性脑梗塞研究[A];第三届全国中西医结合神经系统疾病学术会议论文集[C];2000年
6 尤士杰;杨跃进;陈可冀;吴永健;荆志成;张健;胡奉环;白东峰;唐熠达;高润霖;;通心络胶囊在急性心肌梗死血运重建后的有效性和安全性研究[A];中华医学会心血管病分会第八次全国心血管病学术会议汇编[C];2004年
7 王雯霞;胡新央;虞敏佳;王建安;;通心络促进骨髓间充质干细胞血管新生和迁移能力的研究[A];第十三次全国心血管病学术会议论文集[C];2011年
8 杨宁;;通心络及其超微粉胶囊对患者胃肠道影响的临床分析[A];江西省第四次中西医结合心血管学术交流会论文集[C];2008年
9 徐振刚;;通心络治前列腺增生临床观察[A];第一届全国中西医结合男科学术会议论文汇编[C];2001年
10 曹灵;孙兴旺;程鹏;谭宗凤;张瑶;张燕;;阿魏酸钠对膜性肾病大鼠肾组织中TGF-β1、p-Smad2/3、PA、PAI-1表达的影响及意义[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
相关重要报纸文章 前10条
1 记者 任壮;通心络保护血管内皮作用论文在美杂志发表[N];中国中医药报;2011年
2 通讯员 杨叁平;中药通心络获国际认可[N];科技日报;2011年
3 记者 熊昌彪;通心络保护内皮抑制动脉硬化获国际认可[N];中国医药报;2011年
4 记者 孙国根 通讯员 孙爱军;中药通心络为何可以保护心血管[N];健康报;2011年
5 记者 熊昌彪;通心络稳定斑块研究论文在美国权威杂志发表[N];中国医药报;2010年
6 王志芳 曾荇 曾灿荣 郑华 滕中华 马立勤;通心络治疗冠心病研究进展[N];中国中医药报;2010年
7 黄勇;高科技引导下的现代中药——“以岭通心络”[N];健康报;2002年
8 沈兴;中成药“通心络”治冠心病有重大突破[N];中国高新技术产业导报;2001年
9 ;以岭通心络开辟心脑血管病防治新途径[N];中国中医药报;2004年
10 记者 熊昌彪;通心络可促进急性心梗介入后心肌再灌注[N];中国医药报;2009年
相关博士学位论文 前10条
1 葛华;MAPK和PKC在大鼠动脉球囊损伤术后的表达及通心络干预治疗的影响[D];中国医科大学;2003年
2 王洪巨;血管内皮功能与动脉粥样硬化的关系及通心络干预作用的研究[D];浙江大学;2004年
3 张子新;通心络抑制家兔血管成形术后内膜增殖及血管重构的研究[D];中国医科大学;2002年
4 詹华奎;通心络治疗慢性肾小球肾炎临床研究[D];成都中医药大学;2005年
5 郭晖;PAI-1基因启动区4G/5G多态性与2型糖尿病并发脑梗死以及人脂肪组织表达PAI-1的关系[D];吉林大学;2004年
6 关启刚;炎症因子介导的小型猪冠状动脉痉挛Rho激酶的作用机制与通心络干预研究[D];中国医科大学;2006年
7 蔡平平;多囊卵巢综合征内皮细胞损伤及活血化瘀法对其影响[D];广州中医药大学;2006年
8 马琦琳;IGF-1对血管内皮的保护作用及机制研究[D];中南大学;2007年
9 孙承波;晚期糖基化终产物调节内皮祖细胞功能及其机制研究[D];第二军医大学;2007年
10 贾振华;冠心病心绞痛中医证候量化辨证标准及络气虚滞型动脉粥样硬化大鼠模型病理生理学基础研究[D];河北医科大学;2008年
相关硕士学位论文 前10条
1 宋子凯;通心络对家兔动脉粥样硬化模型VCAM-1及PAI-1表达的影响[D];吉林大学;2011年
2 常丽萍;通心络对局灶性脑缺血大鼠微血管新生及其代偿作用的实验研究[D];河北医科大学;2011年
3 吴守彩;通心络对糖尿病大鼠肾脏的保护作用及分子机制的研究[D];山东大学;2010年
4 周龙岗;通心络对β-淀粉样蛋白脑室注射所致阿尔茨海默病模型大鼠干预作用研究[D];河北医科大学;2010年
5 刘冬梅;通心络对家兔血管成形术后细胞凋亡及基因蛋白表达的影响[D];中国医科大学;2003年
6 赵田田;中药通心络对糖尿病大鼠心肌纤维化预防作用的实验研究[D];辽宁医学院;2011年
7 王雯霞;神经生长因子和通心络对骨髓间充质干细胞血管新生能力的影响[D];浙江大学;2011年
8 李明;白藜芦醇对小鼠动脉粥样硬化模型PAI-1和TNF-α表达的影响[D];吉林大学;2012年
9 王敏;羟苯磺酸钙对慢性肾功能不全大鼠t-PA、PAI-1表达的影响[D];中国医科大学;2010年
10 孔丽丽;GSK3β抑制剂对糖尿病肾病大鼠肾组织TGF-β1和血清PAI-1表达的影响[D];吉林大学;2012年
,本文编号:1477775
本文链接:https://www.wllwen.com/xiyixuelunwen/1477775.html